Skip to main content
Fig. 3 | Journal of Inflammation

Fig. 3

From: A human and animal model-based approach to investigating the anti-inflammatory profile and potential of the 5-HT2B receptor antagonist AM1030

Fig. 3

The effect of AM1030 and reference drugs on LPS- and SEA-induced cytokine responses in mice. a Effect of AM1030, CsA and RS127445 on LPS-induced TNF. AM1030 and CsA (30 mg/kg; n = 7-8/group) were administered subcutaneously 30 min before intraperitoneal injection of 0.5 mg/kg LPS (left). RS127445 (10 mg/kg; n = 8-9/group) was administered subcutaneously 15 min before LPS injection (right). TNF was analysed in plasma samples obtained 90 min after LPS injection. Vehicles were 5 % Kolliphor®EL, 20 % Tween 80 in normal saline (AM1030 and CsA) and normal saline (RS127445). b Effect of AM1030, CsA, tacrolimus and RS127445 on SEA-induced IL-2. AM1030, CsA (30 mg/kg; n = 7-8/group) and tacrolimus (3 mg/kg; n = 4/group) were administered subcutaneously 30 min before intraperitoneal injection of 0.5 mg/kg SEA. RS127445 (10 mg/kg; n = 8/group) was administered perorally 45 min before SEA injection. Vehicles were 5 % Kolliphor®EL, 20 % Tween 80 in normal saline (AM1030, CsA, tacrolimus) and 2.5 % Tween 80 in tap water (RS127445). c Effect of AM1030, CsA and RS127445 on SEA-induced IL-12. AM1030 and CsA (30 mg/kg; n = 7-8/group) were administered subcutaneously 30 min before intraperitoneal injection of 0.5 mg/kg SEA. RS127445 (10 mg/kg; n = 7-8/group) was administered perorally 45 min before SEA injection. Vehicles were 5 % Kolliphor®EL, 20 % Tween 80 in normal saline (AM1030 and CsA) and 2.5 % Tween 80 in tap water (RS127445). d Effect of AM1030 and RS127445 on SEA-induced IFN-ɣ. AM1030 was administered subcutaneously 30 min before intraperitoneal injection of 0.5 mg/kg SEA (n = 8-10/group). RS127445 was administered perorally 45 min before SEA injection (10 mg/kg; n = 6-8/group). Vehicles were 10 % Tween 80 in normal saline (AM1030) and 2.5 % Tween 80 in tap water (RS127445). e Effect of AM1030 on SEA-induced IL-17. AM1030 was administered subcutaneously 30 min before intraperitoneal injection of 0.5 mg/kg SEA (n = 7-8/group). The vehicle was 5 % Kolliphor®EL, 20 % Tween 80 in normal saline. One-way ANOVA with Dunnett’s post-test and unpaired t-test were used for statistical analyses as appropriate (**p < 0.01, ***p < 0.001)

Back to article page